Crossmark

The appropriateness of PSMA PET/CT in newly diagnosed unfavorable intermediate-risk prostate cancer patients—towards a tumor volume-based risk stratification

Crossref DOI link: https://doi.org/10.1038/s41391-024-00899-9

Published Online: 2024-09-23

Published Print: 2025-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hagens, Marinus J. https://orcid.org/0000-0001-6699-0201
Luining, Wietske I.

Boevé, Liselotte M. S.

Knol, Remco J. J.

Roeleveld, Ton A.

Srbljin, Sandra

Weltings, Saskia

Koppes, Jose C. C.

Oprea-Lager, Daniela E.

Vis, André N. https://orcid.org/0000-0003-3419-3368
van Leeuwen, Pim J.

van der Poel, Henk G.
License Information

Text and Data Mining valid from 2024-09-23

Version of Record valid from 2024-09-23
More Information

Article History

Received: 3 June 2024

Revised: 1 September 2024

Accepted: 17 September 2024

First Online: 23 September 2024

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below